Skip to Content
Uncategorized

Illegitimate Pharmaceutical Ads Prolific on Yahoo

The majority of the search engine’s drug ads are from rogue online pharmacies, according to researchers.

82% of drug ads on Yahoo lead to illegitimate Internet pharmacies, according to the second report from spam-monitoring group KnujOn and online pharmacy verifier LegitScripts. At the beginning of this month, these groups released a study suggesting that most of the pharmacy ads appearing on Bing lead users to fraudulent online pharmacies.

LegitScript/KnujOn

By searching Yahoo for terms like ‘generic Viagra’ or ‘pain meds,’ the researchers were able to order several prescription drugs without prescriptions (a violation of federal law) from various countries. The report lists details on 10 ads which led to these ‘rogue’ pharmacies.

In a press release issued today along with the second report, KnujOn founder Garth Bruen said,

“Like Bing, Yahoo! has been infiltrated by sophisticated illicit operations that are taking advantage of consumer need and gullibility.”

The group states that better online pharmacy verification systems are needed to minimize the sales of counterfeit drugs and addictive drugs without prescriptions.

Keep Reading

Most Popular

DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.

“This is a profound moment in the history of technology,” says Mustafa Suleyman.

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

Human-plus-AI solutions mitigate security threats

With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure

Next slide, please: A brief history of the corporate presentation

From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.